← FDA DRUG APPROVALS

FDA ANDA · ANDA201361

EQUATE OMEPRAZOLE AND SODIUM BICARBONATE

omeprazole, sodium bicarbonate

Sponsor: PERRIGO R AND D

APPLICATION
ANDA201361
TYPE
ANDA
ORIGINAL APPROVAL
2016-07-15
LATEST ACTION
2024-02-05
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Over-the-counter

Products

OMEPRAZOLE AND SODIUM BICARBONATEOver-the-counter
OMEPRAZOLE 20MG, SODIUM BICARBONATE 1.1GM · CAPSULE · ORAL

Approval history

2024-02-05Labeling · Supplement 6 · standardAP
2024-02-05Labeling · Supplement 4 · standardAP
2024-02-05Labeling · Supplement 17 · standardAP
2024-02-05Labeling · Supplement 15 · standardAP
2016-07-15Not Applicable · OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →